• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number PAJR071002E
Device Problem Obstruction of Flow (2423)
Patient Problem Stenosis (2263)
Event Date 08/08/2022
Event Type  Injury  
Manufacturer Narrative
No patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.The device remains implanted, and no clinical images enabling direct assessment of product performance were returned for evaluation.A review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.No allegation of device malfunction, such as stent collapse or structural deformation was indicated with respect to device performance.Heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2022 this patient underwent an endovascular treatment of a graft occlusion (thrombosis) with a gore® viabahn® endoprosthesis with propaten bioactive surface (vsx).Reportedly, the lesion type is a restenosis and the patient has had 4 prior known interventional procedures.The pre-procedure stenosis is reported to be a total occlusion and the target lesion is located within the stent graft.The location of the current prosthetic graft being treated is on the left upper arm (axillary vein).On (b)(6) 2022 an adverse event termed thrombosis of avg was discovered and an endovascular surgical intervention was performed on the same day (b)(6) 2022.The patient received an antiplatelet during the procedure.Reportedly, the patency of the vsx was restored at the end of the procedure and patient recovered without any sequelae and was discharged on (b)(6) 2022.
 
Manufacturer Narrative
H6: corrected imdrf codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
wilson okeke
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15518861
MDR Text Key301019531
Report Number2017233-2022-03369
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberPAJR071002E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/04/2022
Initial Date FDA Received09/30/2022
Supplement Dates Manufacturer Received01/17/2023
Supplement Dates FDA Received01/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/24/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
Patient Weight78 KG
-
-